Chinanews, Suzhou, November 3 (Zhou Jianlin, Zhong Sheng) On the 3rd, the 2020 China Biotechnology Innovation Conference opened in Suzhou.
Zhong Nanshan, academician of the Chinese Academy of Engineering, gave a video speech as the chairman of the academic committee of the conference, praising the important role of biotechnology innovation in the prevention and treatment of new coronary pneumonia.
Zhong Nanshan said that since the outbreak of the new crown pneumonia epidemic, China's various biotechnologies have made significant progress and breakthroughs in clinical treatment, vaccine research and development, drugs and testing, and made important contributions to the prevention and control of the epidemic.
At present, biotechnology is accelerating its penetration into the application fields of environment, resources, and health.
The scientific and technological achievements in the field of biotechnology have played a positive role in promoting the national economy.
Zhong Nanshan also pointed out that in recent years, China's biotechnology has made many innovations in human plasma substitutes.
However, there are still problems such as lack of talents, too few independent intellectual property rights, and low industrialization capabilities.
The important instruments and equipment supporting the development of the biotechnology industry mainly rely on foreign imports, resulting in the lack of competitiveness of China's biotechnology innovation products in the international market.
In addition, the talent pool to support the innovation and development of biotechnology is seriously insufficient.
These factors directly lead to the relative lagging behind of developed countries in the industrial application field of China's biotechnology industry.
Facing the new situation and tasks, Zhong Nanshan said that it is necessary to carry out biotechnology innovation and cross-application and common development of technological innovation in different fields of multiple disciplines.
At the same time, through the introduction of talents to strengthen the training of domestic talents, integrate leading domestic and foreign technologies to accelerate the development of biotechnology, and to strengthen the construction of biotechnology scientific research platforms and bases guided by the strategic needs of national goals, to promote human health and social sustainability Development provides strong support.
“This conference has more than 30 academicians and more than 2,000 experts and scholars participating in the conference. The scale of the conference is large and the academic level is high.” Zhong Nanshan looks forward to showing the latest developments in the field of biotechnology through this conference.
Guide all kinds of resources to gather in the field of biotechnology, and promote the innovation and development of biotechnology in China.
"Facing the future, we should build up new confidence, give full play to the advantages of my country's system and mechanism, and actively promote the innovation of biotechnology in major and key technologies in the fields of life sciences and biosafety. In the previous stage, our prevention and control of new coronary pneumonia Achieving success fully reflects the superiority of our system. We must drive basic research with application needs. We will create more scientific and technological achievements in the field of life sciences." Zhong Nanshan said.
(Finish)